Atea Pharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $579k | 190k | 3.05 |
| 2023-09-30 | $1.8M | 603k | 3.00 |
| 2023-06-30 | $5.6M | 1.5M | 3.74 |
| 2023-03-31 | $5.4M | 1.6M | 3.35 |
| 2022-12-31 | $3.3M | 689k | 4.81 |
| 2022-06-30 | $3.5M | 494k | 7.10 |
| 2022-03-31 | $13M | 1.9M | 7.22 |
| 2021-12-31 | $20M | 2.2M | 8.94 |
| 2021-09-30 | $12M | 333k | 35.06 |
| 2021-06-30 | $4.5M | 211k | 21.47 |
| 2021-03-31 | $1.2M | 20k | 61.67 |
| 2020-12-31 | $7.0M | 168k | 41.78 |